This year the CDC is recommending that just about everyone get the regular seasonal flu vaccine as well as the 2 doses of Swine flu vaccine. Can your body handle 3 vaccines this fall? Did you know that most of this year’s seasonal flu vaccine, as well as the Swine flu vaccine will contain a toxic dose of mercury linked to autism? Additionally, the Swine flu vaccine may contain other toxins like the adjuvant squalene, which is added to boost the immune response, but has been blamed for causing Gulf War Syndrome. Are the risks worth any possible benefits?
The 2009-H1N1 Swine flu is unpredictable and could mutate from its mild form at any time to become more virulent. So far however, it has not mutated during the winter flu season in the Southern Hemisphere which is now ending, said Dr. Nancy Cox, head of the Center for Disease Control Influenza Division. Nevertheless, since they know of nothing else to do to prevent the flu the CDC is recommending that half of all Americans get vaccinated, including health care workers, pregnant women, children and young adults ages 6 months to 24 years old.
Recollections from the Swine Flu Fiasco of 1976
To keep ahead of the virus, the Swine Flu Vaccine is being rushed through production so fast that it may not be given sufficient time for testing to determine whether or not the vaccine is even safe or effective. This is the thing to fear. The truth is that this vaccine could kill more people than the Swine Flu itself, just like the Swine Flu fiasco of 1976, in which the Swine Flu only killed 1 person, but the vaccine killed 25 and caused more than 500 cases of Guillain-Barré syndrome, a paralyzing neuromuscular disorder.
The Swine Flu Vaccine: Too Little, Too Late
The vaccine manufacturers are having difficulty producing sufficient quantities of the Swine flu vaccine. The virus is grown in chicken eggs, and vaccine companies are getting 30% fewer doses per egg than the normal yield for regular winter flu vaccine, according to the FDA’s Dr. Jerry Weir.
The U.S. government has purchased 195 million doses of the Swine Flu vaccine for $7 Billion dollars. Approximately only 45 million doses will be available by the middle of October. The five pharmaceutical companies making the vaccine for the US hope that they will be able to collectively provide an additional 20 million doses per week from mid October through December. This would deliver approximately 240 million doses, enough for 120 million Americans.
Since two shots will be required per person, 45 million doses of the Swine flu vaccine will only cover 22.5 million Americans, who will need a second dose 21 days later. Any possible immunity from the vaccine is not expected to occur for another 30 days after the second vaccine dose. This would make it the middle of December before the first Americans vaccinated can expect any possible immune protection from the vaccine. If the virus comes a little early, any vaccine may be too late.
Three Vaccines in Succession: Too Many, Too Toxic
The CDC is recommending that everyone get the Seasonal Flu vaccine immediately, although there are only 120 million doses available right now. Then, as soon as it is available the CDC also wants you to get two shots of the Swine Flu vaccine. That’s 3 shots within 6 weeks. That’s too many for me to recommend. No studies will be conducted to determine whether or not the injection of 3 shots in a row of 4 different influenza virus strains will have immediate or long term harmful effects. So, if you volunteer to get the shots, you are volunteering to be a part of one very large clinical trial.
The Hippocratic Oath’s first and foremost guiding principal is
First Do No Harm! As a physician, I cannot recommend any vaccine and be true to the Hippocratic Oath.” Clark Hansen, N.M.D.
Toxic levels of Mercury in most doses of Vaccine
Most of the 120 million doses of the 2009-2010 Seasonal Flu Vaccine, as well as most of the 195 million doses of the 2009 Swine flu vaccine will contain toxic levels of mercury.
Mercury is used as a preservative, known as Thimerosal, eventhough the Public Health Service (PHS) agencies, including the FDA, the CDC, the American Academy of Pediatrics (AAP) and vaccine manufacturers agreed in July 1999 that Thimerosal should be reduced or eliminated from all vaccines as soon as possible.
Most injected flu vaccine currently available contains 25 micrograms of mercury in the form of Thimerosal (ethylmercury thiosalicylate). Children first receive one-half of the adult dose, or 12.5 micrograms of mercury, followed within a four week period by a second dose of 12.5 micrograms of mercury, for a total of 25 micrograms.
According to the EPA, the maximum acceptable daily risk level is 0.1 mcg/kg. The current vaccine will inject the average child with 12-17 times the maximum daily amount of mercury recommended by the EPA and the average adult with 3.5 times the maximum amount. However, most concerning is the fact that the vaccines will expose the unborn fetus of a pregnant women to 250 times the maximum recommended dose of mercury.
The EPA guidelines are only recommendations for consumption of methyl-mercury typically consumed in fish. There are no guidelines for the more dangerous practice of “injecting” the more toxic ethyl-mercury directly into the human bloodstream.
Mercury is a known neurotoxin that crosses the blood-brain barrier and is especially dangerous to infants and a developing fetus. Mercury has been causally linked to the dramatically increasing incidence of autism and other neurological diseases. Cases of autism in the U.S. have increased by 1,500 per cent since 1991, which is when vaccines for children doubled, and the number of immunizations is only increasing. Just one in 2,500 children were diagnosed with autism before 1991, whereas one in 166 children now have the disease.
To learn more Mercury Toxicity and Symptoms, click here.
Adjuvant in Swine flu Vaccine More Dangerous than the Virus
Unfortunately the production output of this vaccine is one-third the typical output and the manufactures are racing against the clock to make it available before the virus has already peaked this fall.
If the additive free vaccine doesn’t provide a strong enough immune reaction or there isn’t enough supply to go around, manufacturers could be permitted add immune-system boosters called adjuvants. The U.S. Health and Human Services Department has already contracted for 120 million doses of adjuvant, just in case, even though there’s little information on their safety in children and pregnant women and there will not be time to find out if the vaccines are to be administered in this fall.
According to Meryl Nass, M.D., an authority on the anthrax vaccine,
“A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.”
These adjuvants may be more toxic than Mercury. Squalene, is an oil from shark liver. Squalene was found in the Anthrax vaccine given to Gulf War soldiers and is thought to be associated with causing Gulf War Syndrome. (See Congressional Testimony Record)
According to Dr. Viera Scheibner, Ph.D., a retired principle research scientist for the government of Australia:
“… this adjuvant [squalene] contributed to the cascade of reactions called “Gulf War Syndrome,” documented in the soldiers involved in the Gulf War.
The symptoms they developed included arthritis, fibromyalgia, lymphadenopathy, rashes, photosensitive rashes, malar rashes, chronic fatigue, chronic headaches, abnormal body hair loss, non-healing skin lesions, aphthous ulcers, dizziness, weakness, memory loss, seizures, mood changes, neuropsychiatric problems, anti-thyroid effects, anaemia, elevated ESR (erythrocyte sedimentation rate), systemic lupus erythematosus, multiple sclerosis, ALS (amyotrophic lateral sclerosis), Raynaud’s phenomenon, Sjorgren’s syndrome, chronic diarrhoea, night sweats and low-grade fevers.”
Life-threatening Allergic Reactions are very rare but do occur. Signs of serious allergic reaction can include breathing problems, hoarseness or wheezing, hives, paleness, weakness, a fast heartbeat, or dizziness. If they do occur, it is within a few minutes to a few hours after the shot. These reactions are more likely to occur among persons with a severe allergy to eggs, because the viruses used in the influenza vaccine are grown in hens’ eggs. People who have had a severe reaction to eggs or to a flu shot in the past should not get a flu shot.
Guillain-Barré Syndrome
(GBS) is an illness characterized by fever, nerve damage, and muscle weakness. In 1976 the annual vaccination was associated with moreh than 500 cases of GBS. Several studies have been done to evaluate if other flu vaccines since 1976 were associated with GBS. Only one of the studies showed an association. That study suggested that one person out of 1 million vaccinated persons may be at risk of GBS associated with the vaccine. That means that this year as many as 240 persons may develop GBS from the Flu vaccine.
To read Flu Vaccine adverse events reported to the FDA click here.
Should You Get a Rx for the Anit-Viral Drugs
Tamiflu or Relenza?
Tamiflu and Relenza, both appear to work against the 2009-H1N1 Swine flu. However, the supply of these flu drugs is already depleted and will likely be reserved for hospitalized cases and distributed by the State Health Departments of the states with active cases.
Roche’s Tamiflu is the most effective known drug against Influenza Type A infections and the most frequently prescribed in America. It inhibits the enzyme neuraminidase that stops the virus from spreading, but must be taken within the first 48 hours of onset of symptoms. The US has stockpiled 12 million doses of Tamiflu, which is just enough for 4% of the U.S. population.
Tamiflu is generally well tolerated but can cause side-effects inlcuding mild-to-moderate nausea or vomiting in 10% of the population. The most common side effects are nausea, vomiting, headache and fatigue. Other side-effects include delirium, psychosis and hallucinations, especially in children and young adults. Less common side effects may include bronchitis, sleeplessness and vertigo.
Vaccine Manufacturers Immune from Liability Lawsuits
U.S. Secretary of Health and Human Services, Kathleen Sebelius, has granted vaccine makers total legal immunity from any lawsuits that may result from any new swine flu vaccine. And some states may make the vaccination mandatory by law.
Vaccine makers and all federal officials have been granted total legal immunity from lawsuits that result from any new swine flu vaccine, under a document signed by U.S. Secretary of the Department of Health and Human Services (DHHS), Kathleen Sebelius, in June 2009.
It turns out that DHHS Secretary Sibelius has not only given immunity to the manufactures of swine flu vaccines, but also the makers of Tamiflu and Relenza for injuries stemming from their use against swine flu. She also granted immunity to future swine flu vaccines and “any associated adjuvants.” The order was published in the June 25, 2009 Federal Register.
Since the 1980s, the government has protected vaccine makers against lawsuits over the use of childhood vaccines. A federal court handles all vaccine injury claims and decides who will be paid from a special fund.
The document signed by Secretary Sebelius grants immunity to federal officials and drug manufacturers under the provisions of The Public Readiness and Emergency Preparedness Act (PREPA), a 2006 law for public health emergencies.
Vaccine Rush Sacrifices Safety for Benefit of Manufactures
“Here is the problem,” according to Dr. Meryl Nass, M.D., vaccine expert and board member of the Alliance for Human Research Protection (AHRP):
“Once the PREP Act is invoked to shield manufacturers from liability, the pharmaceutical firms have no financial incentive to make the safest product, and have a negative incentive to test it for safety. As long as they do not deliberately harm consumers of the product, they will not be liable for damages.
Are you following this argument closely? In order to avoid having prior knowledge of possible harm to users of the product, for which they could be found liable, it is in the manufacturers’ best interest to know as little as possible about adverse reactions caused by their product.
Thus manufacturers can be expected to perform minimal testing, as they have been incentivized by PREPA to avoid learning of potential harms related to their product. Thus the speed at which the product will be distributed serves two purposes: it provides the needed excuse to avoid adequate testing, as well as providing rapid vaccine availability.”
Don’t be a part of the Vaccination Experiment!
So far, only two of the six manufacturers have clinical trials underway to test the safety and effectiveness of the Swine flu vaccine. Unfortunately, the results of these clinical trials will not be available until the middle of October at the same time that the vaccine is scheduled to be released to the public.
The Food and Drug Administration may formally approve all of the 195 million doses of the Swine flu vaccine before studies required to prove its safety or how well it works are completed under the guise of urgency and provisions of The Public Readiness and Emergency Preparedness Act (PREP Act). Don’t be part of the experiment!
To read Dr. Hansen’s article: The Top Ten Natural Alternatives to the Flu, click here.
To read Dr. Hansen’s article: Swine Flu Fears: Genuine or Hogwash ? click here.